Van Biesen News Today

Plus, Women in Capital Markets names new chief executive

Plus, Women in Capital Markets names new chief executive

Chatbots and other human-imitating artificial intelligence (AI) applications are conquering an increasingly important place in our lives. The possibilities raised by the latest developments are fascinating, but the fact that something is possible does not yet make it desirable. Given the ethical, legal and social implications of AI, questions on its desirability are increasingly pressing.

World-first peanut allergy drug Palforzia’s poor sales spark concerns over future drug research.

Planning a trip home for the festive season? You can surprise your relatives or friends with an unusual gift from the Grand Duchy

“T HE IMPOSSIBLE can many times become possible,” reflects Albert Bourla, boss of Pfizer. He is talking about the giant American drugmaker’s speedy development (with BioNTech of Germany) of a vaccine against covid-19. The sentiment also applies to the turnaround in the fortunes of the pharmaceutical industry. Listen to this story Enjoy more audio and podcasts oniOSorAndroid. Before the pandemic Big Pharma was in big trouble. It was widely criticised for investing more in marketing than in...

Virtus confirms appointment of academy manager Saturday, 30 January 2021 Virtus has announced the appointment of Debbie van Biesen as the organisation’s academy manager, a new initiative to develop a global hub of research, training and education. The organisation said Van Biesen will join after seven years of full-time postdoctoral research at KU Leuven in Belgium. She will divide her time across both organisations, leveraging on international and evidenced-based knowledge of elite athletes...